Sarkiz D. Issakani

Discovery and Characterization of Substituted Diphenyl Heterocyclic Compounds as Potent and Selective Inhibitors of Hepatitis C Virus Replication

D. Payan, K. Qu, T. Kinsella, 2008, Antimicrobial Agents and Chemotherapy.

Cell cycle regulatory E3 ubiquitin ligases as anticancer targets.

S. Demo, D. Payan, S. Molineaux, 2002, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Identification of the Syk kinase inhibitor R112 by a human mast cell screen.

D. Payan, E. Masuda, Rajinder Singh, 2006, The Journal of allergy and clinical immunology.

Structure activity relationships leading to the identification of the indirect activator of AMPK, R419.

V. Markovtsov, Y. Hitoshi, D. Payan, 2022, Bioorganic & medicinal chemistry.

Discovery and Characterization of Substituted Diphenyl Heterocyclic Compounds as Potent and Selective Inhibitors of Hepatitis C Virus Replication (cid:1)

D. Payan, K. Qu, T. Kinsella, 2008 .

Design, synthesis of diaminopyrimidine inhibitors targeting IgE- and IgG-mediated activation of Fc receptor signaling.

D. Payan, Haoran Zhao, E. Masuda, 2015, Bioorganic & medicinal chemistry letters.

AMPK Activation through Mitochondrial Regulation Results in Increased Substrate Oxidation and Improved Metabolic Parameters in Models of Diabetes

B. Viollet, V. Markovtsov, L. Boros, 2013, PloS one.

Developing structure-activity relationships from an HTS hit for inhibition of the Cks1-Skp2 protein-protein interaction.

D. Payan, L. Tsvetkov, Jianing Huang, 2015, Bioorganic & medicinal chemistry letters.

Application of cultured human mast cells (CHMC) for the design and structure-activity relationship of IgE-mediated mast cell activation inhibitors.

D. Payan, E. Masuda, Hui Li, 2015, Bioorganic & medicinal chemistry letters.